Serotonin transporter and receptor genes significantly impact nicotine dependence through genetic interactions in both European American and African American smokers

Drug and Alcohol Dependence

Volumn 129, Issue 3, 2013, Pages 217-225

  Yang, Zhongli ^a,b   Seneviratne, Chamindi ^b   Wang, Shaolin ^b   Ma, Jennie Z ^c   Payne, Thomas J ^d   Wang, Jundong ^a   Li, Ming D ^b  

^a SHANXI AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

African and European American; Epistatic; Gene by gene interactions; Nicotine dependence; Serotonin receptor 3AB; Serotonin transporter

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR; SEROTONIN TRANSPORTER; THREONINE;

ADULT; AFRICAN AMERICAN; ARTICLE; EUROPEAN AMERICAN; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FAMILY ASSESSMENT; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC EPISTASIS; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTONIN 3A RECEPTOR GENE; SEROTONIN 3B RECEPTOR GENE; SEROTONIN TRANSPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TOBACCO DEPENDENCE;

ADULT; AFRICAN AMERICANS; EPISTASIS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOBACCO USE DISORDER;

EID: 84876080619     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.12.007     Document Type: Article

References (60)

1. Al Koudsi N., Tyndale R.F. Genetic influences on smoking: a brief review. Ther. Drug Monit. 2005, 27:704-709.
2. Awtry T.L., Werling L.L. Acute and chronic effects of nicotine on serotonin uptake in prefrontal cortex and hippocampus of rats. Synapse 2003, 50:206-211.
3. 3 receptor - the relationship between structure and function. Neuropharmacology 2009, 56:273-284.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Beuten J., Ma J.Z., Payne T.J., Dupont R.T., Crews K.M., Somes G., Williams N.J., Elston R.C., Li M.D. Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am. J. Hum. Genet. 2005, 76:859-864.
6. Boess F.G., Martin I.L. Molecular biology of 5-HT receptors. Neuropharmacology 1994, 33:275-317.
7. 3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques. Biochemistry 2001, 40:8419-8429.
8. CDC Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 2000-2004. MMWR 2008, 57:1226-1228.
9. CDC Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR 2009, 58:1227-1232.
10. Connolly C.N., Wafford K.A. The Cys-loop super-family of ligand-gated ion channels: the impact of receptor structure on function. Biochem. Soc. Trans. 2004, 32:529-534.
11. 3B subunit is a major determinant of serotonin-receptor function. Nature 1999, 397:359-363.
12. 3 serotonin receptors on presynaptic nerve terminals. Acta Pharmacol. Sin. 2009, 30:788-794.
13. Drisdel R.C., Sharp D., Henderson T., Hales T.G., Green W.N. High affinity binding of epibatidine to serotonin type 3 receptors. J. Biol. Chem. 2008, 283:9659-9665.
14. Dubin A.E., Huvar R., D'Andrea M.R., Pyati J., Zhu J.Y., Joy K.C., Wilson S.J., Galindo J.E., Glass C.A., Luo L., Jackson M.R., Lovenberg T.W., Erlander M.G. The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit. J. Biol. Chem. 1999, 274:30799-30810.
15. 3 receptor sensitivity predict alcohol and drug dependence. Mol. Psychiatry 2011, 16:1139-1146.
16. Fagerstrom K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 1978, 3:235-241.
17. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
18. Gatt J.M., Williams L.M., Schofield P.R., Dobson-Stone C., Paul R.H., Grieve S.M., Clark C.R., Gordon E., Nemeroff C.B. Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depress. Anxiety 2010, 27:752-759.
19. Gerra G., Garofano L., Zaimovic A., Moi G., Branchi B., Bussandri M., Brambilla F., Donnini C. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 135:73-78.
20. Hahn L.W., Ritchie M.D., Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19:376-382.
21. Heils A., Mossner R., Lesch K.P. The human serotonin transporter gene polymorphism - basic research and clinical implications. J. Neural. Transm. 1997, 104:1005-1014.
22. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996, 66:2621-2624.
23. Horvath S., Xu X., Lake S.L., Silverman E.K., Weiss S.T., Laird N.M. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet. Epidemiol. 2004, 26:61-69.
24. Jasinska A.J., Chua H.F., Ho S.S., Polk T.A., Rozek L.S., Strecher V.J. Amygdala response to smoking-cessation messages mediates the effects of serotonin transporter gene variation on quitting. Neuroimage 2012, 60:766-773.
25. Kendler K.S., Neale M.C., Sullivan P., Corey L.A., Gardner C.O., Prescott C.A. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol. Med. 1999, 29:299-308.
26. Kleijn J., Folgering J.H., van der Hart M.C., Rollema H., Cremers T.I., Westerink B.H. Direct effect of nicotine on mesolimbic dopamine release in rat nucleus accumbens shell. Neurosci. Lett. 2011, 493:55-58.
27. 3AB receptor. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:722-727.
28. Lange C., Lyon H., DeMeo D., Raby B., Silverman E.K., Weiss S.T. A new powerful non-parametric two-stage approach for testing multiple phenotypes in family-based association studies. Hum. Hered. 2003, 56:10-17.
29. Lesch K.P., Jatzke S., Meyer J., Stober G., Okladnova O., Mossner R., Riederer P. Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression. J. Neural. Transm. 1999, 106:1223-1230.
30. Levin E., Icenogle L., Farzad A. Ketanserin attenuates nicotine-induced working memory improvement in rats. Pharmacol. Biochem. Behav. 2005, 82:289-292.
31. Levin E.D., Rezvani A.H. Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. Biochem. Pharmacol. 2007, 74:1182-1191.
32. Levin E.D., Slade S., Johnson M., Petro A., Horton K., Williams P., Rezvani A.H., Rose J.E. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Eur. J. Pharmacol. 2008, 600:93-97.
33. Li M.D., Beuten J., Ma J.Z., Payne T.J., Lou X.Y., Garcia V., Duenes A.S., Crews K.M., Elston R.C. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum. Mol. Genet. 2005, 14:1211-1219.
34. Li M.D., Cheng R., Ma J.Z., Swan G.E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003, 98:23-31.
35. Li M.D., Lou X.Y., Chen G., Ma J.Z., Elston R.C. Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence. Biol. Psychiatry 2008, 64:951-957.
36. Lou X.Y., Chen G.B., Yan L., Ma J.Z., Mangold J.E., Zhu J., Elston R.C., Li M.D. A combinatorial approach to detecting gene-gene and gene-environment interactions in family studies. Am. J. Hum. Genet. 2008, 83:457-467.
37. Maes H.H., Sullivan P.F., Bulik C.M., Neale M.C., Prescott C.A., Eaves L.J., Kendler K.S. A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol. Med. 2004, 34:1251-1261.
38. Maricq A.V., Peterson A.S., Brake A.J., Myers R.M., Julius D. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 1991, 254:432-437.
39. Mihailescu S., Palomero-Rivero M., Meade-Huerta P., Maza-Flores A., Drucker-Colin R. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 1998, 360:31-36.
40. Nayak S.V., Ronde P., Spier A.D., Lummis S.C., Nichols R.A. Nicotinic receptors co-localize with 5-HT(3) serotonin receptors on striatal nerve terminals. Neuropharmacology 2000, 39:2681-2690.
41. Niesler B., Flohr T., Nothen M.M., Fischer C., Rietschel M., Franzek E., Albus M., Propping P., Rappold G.A. Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 2001, 11:471-475.
42. Patkar A.A., Gopalakrishnan R., Berrettini W.H., Weinstein S.P., Vergare M.J., Leone F.T. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers. Psychopharmacol. (Berl.) 2003, 166:221-227.
43. Ribeiro E.B., Bettiker R.L., Bogdanov M., Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993, 621:311-318.
44. Semba J., Wakuta M. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion. Psychiatry Clin. Neurosci. 2008, 62:435-441.
45. Seneviratne C., Huang W., Ait-Daoud N., Li M.D., Johnson B.A. Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensity. Alcohol. Clin. Exp. Res. 2009, 33:332-339.
46. Slotkin T.A., Seidler F.J. Mimicking maternal smoking and pharmacotherapy of preterm labor: interactions of fetal nicotine and dexamethasone on serotonin and dopamine synaptic function in adolescence and adulthood. Brain Res. Bull. 2010, 82:124-134.
47. Staley J.K., Krishnan-Sarin S., Zoghbi S., Tamagnan G., Fujita M., Seibyl J.P., Maciejewski P.K., O'Malley S., Innis R.B. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 2001, 41:275-284.
48. Steen K.V. Travelling the world of gene-gene interactions. Brief. Bioinform 2012, 13:1-19.
49. Sullivan P.F., Kendler K.S. The genetic epidemiology of smoking. Nicotine Tob. Res 1999, 1(Suppl. 2):S51-S57. discussion S69-S70.
50. Sun D., Ma J.Z., Payne T.J., Li M.D. Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. Mol. Psychiatry 2008, 13:398-406.
51. Trummer O., Koppel H., Wascher T.C., Grunbacher G., Gutjahr M., Stanger O., Ramschak-Schwarzer S., Boehm B.O., Winkelmann B.R., Marz W., Renner W. The serotonin transporter gene polymorphism is not associated with smoking behavior. Pharmacogenomics J. 2006, 6:397-400.
52. Vallender E.J., Priddy C.M., Hakim S., Yang H., Chen G.L., Miller G.M. Functional variation in the 3' untranslated region of the serotonin transporter in human and rhesus macaque. Genes Brain Behav. 2008, 7:690-697.
53. Vink J.M., Willemsen G., Boomsma D.I. Heritability of smoking initiation and nicotine dependence. Behav. Genet. 2005, 35:397-406.
54. Walstab J., Rappold G., Niesler B. 5-HT(3) receptors: role in disease and target of drugs. Pharmacol. Ther. 2010, 128:146-169.
55. Wang J., Li M.D. Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. Neuropsychopharmacology 2010, 35:702-719.
56. WHO Report on the Global Tobacco Epidemic 2008: The MPOWER Package 2008, World Health Organization, Geneva.
57. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 1997, 20:92-98.
58. Wonnacott S., Kaiser S., Mogg A., Soliakov L., Jones I.W. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur. J. Pharmacol. 2000, 393:51-58.
59. 2+ sensors. PLoS ONE 2011, 6:e16519.
60. Zuk O., Hechter E., Sunyaev S.R., Lander E.S. The mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1193-1198.